These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 29611528)
21. Doctor Shopping Behavior for Zolpidem Among Insomnia Patients in Taiwan: A Nationwide Population-Based Study. Lu TH; Lee YY; Lee HC; Lin YM Sleep; 2015 Jul; 38(7):1039-44. PubMed ID: 25761979 [TBL] [Abstract][Full Text] [Related]
22. Are guidelines on use of colony-stimulating factors in solid cancers flawed? Haines IE; Olver I Intern Med J; 2009 Apr; 39(4):259-62. PubMed ID: 19402867 [TBL] [Abstract][Full Text] [Related]
23. SOBRINA Spanish study-analysing the frequency, cost and adverse events associated with overuse in primary care: protocol for a retrospective cohort study. Mira JJ; Carrillo I; Gea Velázquez de Castro MT; Silvestre C; Olivera G; Caro-Mendivelso J; Pérez-Pérez P; Agra Y; Fernández AM; Aranaz-Andrés JM; BMJ Open; 2019 Mar; 9(3):e023399. PubMed ID: 30837247 [TBL] [Abstract][Full Text] [Related]
24. Inappropriate use of clinical practices in Canada: a systematic review. Squires JE; Cho-Young D; Aloisio LD; Bell R; Bornstein S; Brien SE; Decary S; Varin MD; Dobrow M; Estabrooks CA; Graham ID; Greenough M; Grinspun D; Hillmer M; Horsley T; Hu J; Katz A; Krause C; Lavis J; Levinson W; Levy A; Mancuso M; Morgan S; Nadalin-Penno L; Neuner A; Rader T; Santos WJ; Teare G; Tepper J; Vandyk A; Wilson M; Grimshaw JM CMAJ; 2022 Feb; 194(8):E279-E296. PubMed ID: 35228321 [TBL] [Abstract][Full Text] [Related]
25. Economic outcomes associated with the use of hematopoietic growth factors. Glaspy JA Oncology (Williston Park); 1995 Nov; 9(11 Suppl):93-105. PubMed ID: 8608062 [TBL] [Abstract][Full Text] [Related]
26. Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist. Deliens C; Deliens G; Filleul O; Pepersack T; Awada A; Piccart M; Praet JP; Lago LD J Geriatr Oncol; 2016 Nov; 7(6):463-470. PubMed ID: 27238734 [TBL] [Abstract][Full Text] [Related]
27. Potentially inappropriate medication in the elderly in Germany: an economic appraisal of the PRISCUS list. Pohl-Dernick K; Meier F; Maas R; Schöffski O; Emmert M BMC Health Serv Res; 2016 Apr; 16():109. PubMed ID: 27039188 [TBL] [Abstract][Full Text] [Related]
28. The state of overuse measurement: a critical review. Chan KS; Chang E; Nassery N; Chang HY; Segal JB Med Care Res Rev; 2013 Oct; 70(5):473-96. PubMed ID: 23804290 [TBL] [Abstract][Full Text] [Related]
29. Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure. Bennette CS; Richards C; Sullivan SD; Ramsey SD Health Aff (Millwood); 2016 May; 35(5):805-12. PubMed ID: 27140986 [TBL] [Abstract][Full Text] [Related]
30. A Practical Framework for Understanding and Reducing Medical Overuse: Conceptualizing Overuse Through the Patient-Clinician Interaction. Morgan DJ; Leppin AL; Smith CD; Korenstein D J Hosp Med; 2017 May; 12(5):346-351. PubMed ID: 28459906 [TBL] [Abstract][Full Text] [Related]
31. Making Wise Choices in Health Provision: Initial Exploration of Nurse Perceptions in Israel. Ellen ME; Horowitz E J Nurs Care Qual; 2018; 33(4):E7-E13. PubMed ID: 29240573 [TBL] [Abstract][Full Text] [Related]
32. Evaluate cost-benefits of new anti-emesis drug. Health Care Cost Reengineering Rep; 1998 Sep; 3(9):141-3. PubMed ID: 10185347 [TBL] [Abstract][Full Text] [Related]
33. A pharmacist-led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer. Nightingale G; Hajjar E; Guo K; Komura S; Urnoski E; Sendecki J; Swartz K; Chapman A J Geriatr Oncol; 2015 Sep; 6(5):411-7. PubMed ID: 26277113 [TBL] [Abstract][Full Text] [Related]
34. 2019 Update on Pediatric Medical Overuse: A Systematic Review. Money NM; Schroeder AR; Quinonez RA; Ho T; Marin JR; Morgan DJ; Dhruva SS; Coon ER JAMA Pediatr; 2020 Apr; 174(4):375-382. PubMed ID: 32011675 [TBL] [Abstract][Full Text] [Related]
35. Polypharmacy in elderly patients with cancer: clinical implications and management. Lees J; Chan A Lancet Oncol; 2011 Dec; 12(13):1249-57. PubMed ID: 21741307 [TBL] [Abstract][Full Text] [Related]
36. Outpatient cancer drug costs: changes, drivers, and the future. Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485 [TBL] [Abstract][Full Text] [Related]
37. Factors associated with the use of potentially inappropriate medications by older adults with cancer. Reis CM; Dos Santos AG; de Jesus Souza P; Reis AMM J Geriatr Oncol; 2017 Jul; 8(4):303-307. PubMed ID: 28602709 [TBL] [Abstract][Full Text] [Related]
38. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population. Divakaruni A; Saylor E; Duffy AP J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636 [TBL] [Abstract][Full Text] [Related]
39. Drug repurposing in oncology--patient and health systems opportunities. Bertolini F; Sukhatme VP; Bouche G Nat Rev Clin Oncol; 2015 Dec; 12(12):732-42. PubMed ID: 26483297 [TBL] [Abstract][Full Text] [Related]
40. Estimating the excess of inappropriate prescriptions of anti-dopaminergic anti-emetics during acute gastroenteritis epidemics in France. Roussel V; Tritz T; Souty C; Turbelin C; Arena C; Lambert B; Lillo-Lelouët A; Kernéis S; Blanchon T; Hanslik T Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1080-5. PubMed ID: 23935001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]